Intrinsic Value of S&P & Nasdaq Contact Us

Xenon Pharmaceuticals Inc. XENE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CA • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$76.67
+29.2%

Xenon Pharmaceuticals Inc. (XENE) has 12 identified peers for comparison in the Healthcare sector. Peers include ACLX, ANAB, ASND, CRNX, CYTK, DICE and others.

XENE has a market capitalization of $4.69B, compared to an average peer market cap of $4.13B.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message